NIH-funded research R01 grant

How cannabinoids affect the brain’s protective barrier in people with HIV

Official title: Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain

Funded at San Diego Biomedical Research Institute · NIH-11364256 · Data updated 2026-11-12

This project studies how cannabis compounds influence the brain’s protective barrier in people living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSan Diego Biomedical Research Institute
NIH-funded
Lab location1 site (San Diego, United States)
Project startAugust 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$809,164
NIH project number5R01DA059344-03
Project IDNIH-11364256 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV who might use cannabis and whose brain health could be affected by HIV-related BBB changes.

Less likely to help

Individuals without HIV or those not impacted by HIV-related BBB disruption are unlikely to benefit from this research.

What this research studies

Researchers will explore how cannabinoids interact with HIV in the brain and how this changes the blood-brain barrier. They will look at how immune and brain cells respond to cannabis in the context of HIV and ART, using lab studies on human brain cells and relevant models. The goal is to understand mechanisms that could influence brain inflammation, virus activity, and drug delivery to the CNS. Findings could point to new ways to protect brain health in people with HIV who use cannabis.

Why it matters

Potential benefit: If successful, this work could clarify whether cannabis helps or harms brain protection in HIV, potentially guiding safer use and informing future treatments.

How similar studies have gone: Previous observations suggest context-dependent effects of cannabis on BBB, but the exact mechanisms in HIV are still being explored.

Where this research is happening

  • San Diego Biomedical Research Institute
    San Diego, United States
    Active

Researchers

  • Principal investigator: Marcondes, Maria Cecilia Garibaldi — San Diego Biomedical Research Institute
  • Study coordinator: Marcondes, Maria Cecilia Garibaldi

Related research

Other NIH-funded projects on the same topics.

  • Immunize to Build Broad HIV Antibodies

    A HIV vaccine grant tests new lab-made proteins and vaccines designed to help the immune system produce broadly protective antibodies for people at risk of HIV.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11510034

  • How cancer-linked pathways create fragile spots in DNA

    This project looks at how cancer-related cellular pathways make weak spots in chromosomes so patterns in a tumor's genome can point to the pathways driving that cancer.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11473636

  • Cis-acting elements that control when DNA replication starts in development

    Researchers are studying specific DNA sequences that help determine when and how quickly DNA replication happens in early cell development, with potential implications for cancer.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11412661

  • Nanoscale imaging of HIV Env complexes to improve NK cell antibody therapies

    A study to better understand how HIV envelope immune complexes affect natural killer cell antibody therapies and how to design better antibodies.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11412173

  • Meth and HIV in the brain: how meth use may affect HIV latency and brain cells

    A study to understand how methamphetamine use might change HIV behavior in brain cells and how that could influence HIV persistence and brain health in people living with HIV.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11405037

  • Role of a special interferon-responsive T cell in allergies and asthma

    A study explores a unique interferon-responsive T cell type that may influence allergies and asthma, aiming to understand why some people become allergic and how this T cell subset could affect airway inflammation.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11389644

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.